127 related articles for article (PubMed ID: 8098391)
21. Prevalence of human parvovirus B19 in sickle cell disease and healthy controls.
Teuscher T; Baillod B; Holzer BR
Trop Geogr Med; 1991; 43(1-2):108-10. PubMed ID: 1661040
[TBL] [Abstract][Full Text] [Related]
22. Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease.
Wierenga KJ; Pattison JR; Brink N; Griffiths M; Miller M; Shah DJ; Williams W; Serjeant BE; Serjeant GR
Lancet; 1995 Aug; 346(8973):475-6. PubMed ID: 7637482
[TBL] [Abstract][Full Text] [Related]
23. Transient aplastic crisis in a leukemic child caused by parvovirus B19 infection.
Mihál V; Dusek J; Hajdúch M; Cohen BJ; Fingerová H; Veselý J
Pediatr Hematol Oncol; 1996; 13(2):173-7. PubMed ID: 8721033
[TBL] [Abstract][Full Text] [Related]
24. Parvovirus associated aplastic crisis in homozygous sickle cell disease.
Goldstein AR; Anderson MJ; Serjeant GR
Arch Dis Child; 1987 Jun; 62(6):585-8. PubMed ID: 3039926
[TBL] [Abstract][Full Text] [Related]
25. Aplastic crisis associated with parvovirus B19 in an adult with hereditary spherocytosis.
Beland SS; Daniel GK; Menard JC; Miller NM
J Ark Med Soc; 1997 Sep; 94(4):163-4. PubMed ID: 9308316
[TBL] [Abstract][Full Text] [Related]
26. Aplastic anemia due to B19 parvovirus infection in cadaveric renal transplant recipients: an underestimated infectious disease in the immunocompromised host.
Bertoni E; Rosati A; Zanazzi M; Azzi A; Zakrzewska K; Guidi S; Fanci R; Salvadori M
J Nephrol; 1997; 10(3):152-6. PubMed ID: 9238623
[TBL] [Abstract][Full Text] [Related]
27. [Observations on human parvovirus B19 infection diagnosed in 2011].
Mihály I; Trethon A; Arányi Z; Lukács A; Kolozsi T; Prinz G; Marosi A; Lovas N; Dobner IS; Prinz G; Szalai Z; Pék T
Orv Hetil; 2012 Dec; 153(49):1948-57. PubMed ID: 23204301
[TBL] [Abstract][Full Text] [Related]
28. Human serum parvovirus as the cause of aplastic crisis in sickle cell disease.
Kelleher JF; Luban NL; Cohen BJ; Mortimer PP
Am J Dis Child; 1984 Apr; 138(4):401-3. PubMed ID: 6322575
[TBL] [Abstract][Full Text] [Related]
29. Aplastic and hypoplastic episodes in sickle cell disease and thalassaemia intermedia.
Brownell AI; McSwiggan DA; Cubitt WD; Anderson MJ
J Clin Pathol; 1986 Feb; 39(2):121-4. PubMed ID: 3005372
[TBL] [Abstract][Full Text] [Related]
30. Transmission of human parvovirus B19 by plasma derived factor VIII concentrates.
Laurian Y; Dussaix E; Parquet A; Chalvon-Demersay A; d'Oiron R; Tchernia G
Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):449-53. PubMed ID: 7753615
[TBL] [Abstract][Full Text] [Related]
31. Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent.
Serjeant GR; Topley JM; Mason K; Serjeant BE; Pattison JR; Jones SE; Mohamed R
Lancet; 1981 Sep; 2(8247):595-7. PubMed ID: 6116082
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and incidence of erythrovirus B19 infection in children with sickle cell disease: The impact of viral infection in acute clinical events.
dos Santos Brito Silva Furtado M; Viana MB; Hickson Rrios JS; Gontijo RL; Silva CM; do Val Rezende P; de Figueiredo RM; Martins ML
J Med Virol; 2016 Apr; 88(4):588-95. PubMed ID: 26369294
[TBL] [Abstract][Full Text] [Related]
33. An epidemic of aplastic crisis caused by human parvovirus B19.
Mallouh AA; Qudah A
Pediatr Infect Dis J; 1995 Jan; 14(1):31-4. PubMed ID: 7715986
[TBL] [Abstract][Full Text] [Related]
34. [Parvovirus B19 infection: the general aspects and gestational problems].
Di Stefano L; Carta G; Barnabei R; Tomei E; Toro G; Moscarini M
Minerva Ginecol; 1995 Apr; 47(4):121-5. PubMed ID: 7644092
[TBL] [Abstract][Full Text] [Related]
35. [The use of real-time polymerase chain reaction and enzyme immunoassay for the diagnosis of acute parvovirus B19 infections in immunosuppressed patients].
Işik N; Ağaçfidan A; Ağirbaşli H; Işik DM; Bozkaya E; Gedikoğlu G; Badur S
Mikrobiyol Bul; 2003 Oct; 37(4):277-83. PubMed ID: 14748265
[TBL] [Abstract][Full Text] [Related]
36. Parvovirus infection in children with AIDS: high prevalence of B19-specific immunoglobulin M and G antibodies.
Nigro G; Luzi G; Fridell E; Ferrara M; Pisano P; Gattinara GC; Mezzaroma I; Söderlund M; Rasnoveanu D; Aiuti F
AIDS; 1992 Jul; 6(7):679-84. PubMed ID: 1503687
[TBL] [Abstract][Full Text] [Related]
37. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus.
Chernak E; Dubin G; Henry D; Naides SJ; Hodinka RL; MacGregor RR; Friedman HM
Clin Infect Dis; 1995 Jan; 20(1):170-3. PubMed ID: 7727646
[TBL] [Abstract][Full Text] [Related]
38. Parvovirus B19 in human disease.
Brown KE; Young NS
Annu Rev Med; 1997; 48():59-67. PubMed ID: 9046945
[TBL] [Abstract][Full Text] [Related]
39. [Erythema infectiosum in pregnancy. A follow-up of children after 2 years].
Bruu AL; Flugsrud LB
Tidsskr Nor Laegeforen; 1994 Jan; 114(3):308-10. PubMed ID: 8191425
[TBL] [Abstract][Full Text] [Related]
40. Life threatening parvovirus B19 and herpes simplex virus associated acute myocardial dysfunction in a child with homozygous sickle cell disease.
Krishnamurti L; Lanford L; Munoz R
Pediatr Blood Cancer; 2007 Dec; 49(7):1019-21. PubMed ID: 16700044
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
